Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: A magnetic resonance spectroscopy study in vivo

Cancer Chemotherapy and Pharmacology

Volumn 42, Issue 3, 1998, Pages 201-209

  Lemaire, Laurent P ^a,b   McSheehy, Paul M J ^a   Griffiths, John R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UMR 5623 CNRS UPS)   (France)

Author keywords

5 Fluorouracil; 19F 31P NMR spectroscopy; Primary tumours

Indexed keywords

FLUORINE; FLUORINE DERIVATIVE; FLUOROURACIL;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; DRUG METABOLISM; DRUG RESPONSE; DRUG RETENTION; DRUG UPTAKE; ENERGY METABOLISM; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; PREDICTION; PRIORITY JOURNAL; RAT; TUMOR; TUMOR GROWTH; TUMOR VOLUME;

ANALYSIS OF VARIANCE; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOGENS; ENERGY METABOLISM; FEMALE; FLUOROURACIL; MAGNETIC RESONANCE SPECTROSCOPY; METHYLNITROSOUREA; NEOPLASMS, EXPERIMENTAL; ORGAN SIZE; RATS; RATS, WISTAR;

EID: 0031847282     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050806     Document Type: Article

References (26)

1. Heidelberger C, Danenberg PV, Moran G (1983) Fluorinated pyrimidines and their nucleosides. Adv Enzymol 54: 58-119
2. Danenberg PV, Langenbach RJ, Heidelberger C (1974) Structures of reversible and irreversible complexes of thymidylate synthase and fluorinated pyrimidine nucleotides. Biochemistry 13: 926-933
3. Jacquez JA (1962) Permeability of Ehrlich cells to uracil, thymidine and fluorouracil. Proc Soc Exp Biol Med 109: 132-135
4. Wolhueter RM, McIvor RS, Plagemann PGW (1980) Facilitated transport of uracil and 5-fluorouracil, and permeation of orotic acid into cultured mammalian cells. J Cell Physiol 104: 309-319
5. 19F nuclear magnetic resonance spectroscopy. Cancer Res 51: 5770-5773
6. Yamamoto S-I, Kawasaki T (1981) Active transport of 5-fluorouracil and its energy coupling in Ehrlich ascites tumour cells. J Biochem 90: 635-642
7. Ojugo ASE, McSheehy PMJ, Stubbs M, Alder G, Bashford CL, Maxwell RJ, Leach MO, Judson IR, Grifliths JR (1998) Influence of pH on the uptake of 5-fluorouracil into isolated tumour cells. Br J Cancer 77: 873-879
8. 19F NMR spectroscopic pharmacokinetics in tumour-bearing humans and rabbits. Proc Natl Acad Sci USA 87: 492-496
9. Newell DR, Maxwell RJ, Golding BT (1992) In vivo and ex vivo magnetic resonance spectroscopy as applied to pharmacokinetic studies with anticancer agents: a review. Nucl Magn Reson Biomed 5: 273-278
10. Findlay M, Leach MO (1994) In vivo monitoring of fluoropyrimidine metabolites: magnetic resonance spectoscopy in evaluation of 5-fluorouracil. Anticancer Drugs 5: 260-280
11. 19F MRS studies of fluoropyrimidine chemotherapy. A review. Nucl Magn Reson Biomed 2: 133-141
12. Presant CA, Wolf W, Waluch V, Wiseman C, Kennedy P, Blayney D, Brechner RR (1994) Association of intratumoral pharmacokinetics of fluorouracil with clinical response. Lancet 343: 1184-1187
13. Gullino PM, Pettigrew HM, Grantham FH (1975) N-Nitrosomethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst 54: 401-414
14. 31P-NMR spectroscopy and histological studies of the response of rat mammary tumours to endocrine therapy. Br J Cancer 61: 258-262
15. Cleton FJ (1995) Chemotherapy: general aspects. In: Peckham M, Pinedo HM, Veronesi U (eds) Oxford textbook of oncology, vol I. Oxford University, Oxford, pp 445-453
16. 31P-NMR signals using the variable projection method and prior knowledge. Magn Reson Med 6: 92-98
17. 31P MRS studies of phosphate metabolites and pH in rat tumours. Nucl Magn Reson Biomed 6: 43-52
18. 31P MRS as a method of measuring pH in rat tumours. Nucl Magn Reson Biomed 5: 351-359
19. Bland M (1995) An introduction to medical statistics, 2nd edn. Oxford Medical Publications, Oxford
20. Baluch S, (1993) Studies using magnetic resonance spectroscopy for the assessment of tumour response. PhD thesis (Univ. of London) Ch. 2, p 45
21. 19F NMR spectroscopy Magn Reson Med 36: 445-450
22. 19F magnetic resonance spectroscopy in patients with colorectal cancer: a pilot study. Ann Oncol 4: 597-602
23. 19F NMR study of 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma. Magn Reson Imaging 12: 497-511
24. McSheehy PMJ, Stubbs M, Ojugo ASE, Box C, McCoy CL, Leach MO, Judson IR, Griffiths JR (1997) The relationship between intra- and extracellular pH in solid tumours in vivo (abstract). Proc Int Soc Magn Reson Med 5: 1095
25. Sijens PE, Baldwin NJ, Ng TC (1991) Multinuclear NMR investigation of the metabolic response of the murine RIF-I tumour to 5-fluorouracil chemotherapy. Magn Reson Med 19: 373-385
26. 19F nuclear magnetic resonance spectroscopy study in vivo. Cancer Chemother Pharmacol 37: 259-265